1 – 10 of 35
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Effects of levodopa–entacapone–carbidopa intrajejunal infusion on non-motor symptoms of advanced Parkinson’s disease—interim analysis of the ELEGANCE study
(2025) In Journal of Neural Transmission
- Contribution to journal › Article
-
Mark
Far from being the end of the road : taking a closer look at neuropalliative care in Parkinson’s disease
- Contribution to journal › Scientific review
- 2024
-
Mark
Monotherapy with infusion therapies – useful or not?
- Contribution to journal › Scientific review
- 2023
-
Mark
Homocysteine, vitamin B metabolites, dopamine-substituting compounds, and symptomatology in Parkinson’s disease : clinical and therapeutic considerations
- Contribution to journal › Scientific review
- 2020
-
Mark
Tolerability of non-ergot oral and transdermal dopamine agonists in younger and older Parkinson’s disease patients : an European multicentre survey
- Contribution to journal › Article
- 2019
-
Mark
Disease stage dependency of motor and non-motor fluctuations in Parkinson's disease
- Contribution to journal › Article
- 2018
-
Mark
The serotonergic system in L-DOPA-induced dyskinesia : pre-clinical evidence and clinical perspective
- Contribution to journal › Article
-
Mark
Animal models of l-DOPA-induced dyskinesia : the 6-OHDA-lesioned rat and mouse
- Contribution to journal › Article
-
Mark
On the neuronal circuitry mediating l-DOPA-induced dyskinesia
- Contribution to journal › Article
- 2015
-
Mark
Quantitative assessment of non-motor fluctuations in Parkinson's disease using the Non-Motor Symptoms Scale (NMSS)
- Contribution to journal › Article
